ProAbTech is a Korean biopharma company with a novel platform
technology that develops long-acting biopharmaceuticals
with improved efficacy and stability in the body over current drugs.
We have developed a novel method for creating stable and
long-acting biologically based drugs by exploiting site-specific
bioconjugation technology, and especially focused on the areas
of metabolic diseases, anti-cancer, and rare diseases.
The ProAbTech team has obtained several patents
and trademarks protecting their technology.
Responding the unmet medical needs, we hope to provide these
opportunities of innovative treatment options to patients
for their improved quality of life.